Secukinumab after first-line tumor necrosis factor-alpha inhibitor therapy in psoriatic arthritis: A real-world retrospective cohort study
Volume 39 - Issue 1 - March 2024, Page 071-080
Serdal Uğurlu

Enter the code above.